David Ríos Covián, Director of Technology Development at Microviable Therapeutics, will participate in the 24th Drug Discovery Innovation Programme that will take place on 19-20 September in Barcelona.
Particularly, David Rios will be present as a panelist at the roundtable moderated by Anna Puszkarska (Sanofi) in which he will discuss “The Future of AI in Drug Discovery” together with Fred Manby, Co-Founder and CTO at Iambic Therapeutics.
Drug Discovery Innovation Programme, is an exciting event showcasing groundbreaking discoveries and innovative ideas in the field of drug discovery. Engage with renowned speakers and industry leaders through interactive sessions, exhibitions, booths, and numerous networking opportunities. Whether you are a researcher, scientist, or industry professional, this event is essential for anyone interested in the latest advancements in drug development.
Meet with us at the event! We are thrilled to invite you to explore potential strategic partnership opportunities. Our mission is to develop novel biological drugs to address unmet challenges in human diseases providing innovative microbiota-based solutions for oncology and infectious diseases.
Contact David Rios: david.rios@microviable.com